Zoetis is trading 4.1% down at $72.27, despite broader U.S. indexes trading higher, after the company lowered 2026 adjusted EPS guidance.

  • Following the August 6 earnings release, Citigroup cut its price target to $96 from $112 while maintaining Buy.
  • Zoetis reduced 2026 adjusted EPS guidance to $6.15–$6.25 from $6.85–$7.00, citing softer pet-health demand and competition.
  • No reliable volume data was available; confidence is medium.